Search Results for: Marc Tessier-Lavigne
The annual recipient of the NY/NJ CEO Lifetime Achievement Award is nominated and elected by peers from within the biotechnology industry and it recognizes the extraordinary contributions of the awardees toward advancing medical science and products that address unmet medical needs, as well as in helping to create an environment that fosters the growth of the industry in the New York metropolitan area.
Congress of the United States U.S. House of Representatives Committee on Science, Space, and Technology Subcommittee on Research and Technology “Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients” Written Testimony of Dr. Marc Tessier-Lavigne Rayburn House Office Building … More »
Medical innovation requires federal support and structural improvements, Marc Tessier-Lavigne tells members of Congress
Speaking at a hearing on public versus private contributions to medical breakthroughs, Rockefeller’s president explained the ecosystem responsible for taking a biological insight on, for example, how tumors spread, and turning it into a treatment that improves or saves lives. He also offered suggestions for how the federal government could further encourage such breakthroughs.
Tessier-Lavigne, Rockefeller president and head of the Laboratory of Brain Development, and Jeffrey M. Friedman head of the Laboratory of Molecular Genetics, were elected to the honorary society and independent policy research center along with 198 other leaders in science, art, academia and the civic, corporate and philanthropic arenas. The current membership includes some 250 Nobel laureates and more than 60 Pulitzer Prize winners, and 23 other Rockefeller University faculty members are fellows.
President Marc Tessier-Lavigne will receive the Henry G. Friesen International Prize in Health Research, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences to recognize exceptional innovation by a visionary health leader of international stature.
A world leader in the study of brain development, Tessier-Lavigne has pioneered the identification of the molecules that direct the formation of connections among nerve cells to establish neuronal circuits in the mammalian brain and spinal cord. Tessier-Lavigne is among 65 new members and five foreign associates elected to the Institute this year. More »
Rockefeller University’s President will receive the Memorial Sloan-Kettering Medal for Outstanding Contributions to Biomedical Research at MSKCC’s 2011 Academic Convocation. More »
Marc Tessier-Lavigne, a leading neuroscientist and the former chief scientific officer of Genentech, takes over as president of The Rockefeller University today, replacing Paul Nurse, who has left to become president of the Royal Society in London. More »
The university’s Board of Trustees has elected Tessier-Lavigne to succeed Paul Nurse on March 11, 2011. A leader in the study of brain development, he is currently executive vice president for research and chief scientific officer at Genentech, one the world’s leading biotech companies. More »
Genentech Brain Trust Leaves With $217 Million For New Startup To Fight Alzheimer’s And Parkinson’s “Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to … More »
The award recognizes Fuchs’s contributions to our understanding of skin biology and skin stem cells, including discoveries that have led to advancements in treating skin cancer and severe burns.
In the developing nervous system, some neurons must extend their branches to connect one half of the brain with the other. A new study sheds light on the molecular mechanisms that guide the winding paths of their axons. More »
Gabriel Victora, an immunologist who studies the processes by which the immune system refines its response to an infection, will establish the Laboratory of Lymphocyte Dynamics in September of 2016 where he will study antibody responses at the levels molecules, cells, and whole organs. More »
With his election, Casanova, who investigates the genetic underpinnings of unusual vulnerability to specific infectious diseases among young people, receives one of the highest honors within the field of medicine. Seventeen Rockefeller scientists are currently members of the academy of medicine. More »
Alipasha Vaziri, who was appointed a tenure-track associate professor in September, seeks to capture and manipulate interactions among neurons within the living brain. He uses his background in physics to develop innovative ways of recording neural activity quickly and across large areas, all at single-cell resolution. More »
The Kavli Foundation and The Rockefeller University today announced the formation of the Kavli Neural Systems Institute (Kavli NSI) at Rockefeller, funded by a $20 million endowment supported equally by Kavli and Rockefeller. The Institute will become part of a network of seven Kavli Institutes carrying out fundamental research in neuroscience, and a broader network of 20 Kavli Institutes dedicated to astrophysics, nanoscience, neuroscience, and theoretical physics. More »